Since previous studies suggested the involvement of isoform shift from 3 to 1 in carcinoma progression [16,33], we treated cells with tumor stimulus (TGF-β, EGF and TNF-α) that facilitate the progression [34–36] and examined the shift. Here, EGF is linked to carcinoma.